ECL1i
ECL1i is an allosteric and selective CCR2 inhibitor. It specifically suppresses CCL2-/CCR2-mediated chemotaxis. ECL1i can disrupt the recruitment of CCR2-positive cells and alleviate the progression of experimental autoimmune encephalomyelitis.
Product Specifications
Molecular Weight
780.98
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog